Iain Peter Murray Buchanan

Directeur/Membre du Conseil chez Allecra Therapeutics GmbH

Profil

Iain Peter Murray Buchanan is currently a Non-Executive Director at Allecra Therapeutics GmbH, a Director at Aurealis Oy, a Director at Aurealis Pharma AG, and a Non-Executive Director at Celloryx AG.
Previously, he served as the Chief Executive Officer of Novexel SA from 2009 to 2010, the Chief Executive Officer of NOXXON Pharma AG from 2012 to 2015, and a Non-Executive Director of Synairgen Plc from 2010 to 2022.
He also held positions as the Licensing Director at Cilag AG from 1987 to 1994, the Managing Director at Vertex Pharmaceuticals (Europe) Ltd., the Marketing Director at Biogen SA from 1981 to 1987, and the Vice President-European Operations at Vertex Pharmaceuticals, Inc. from 1994 to 2004.
Additionally, he worked as a Principal at Organon Pharma (UK) Ltd. Mr. Buchanan obtained his undergraduate degree from the University of St. Andrews.

Postes actifs de Iain Peter Murray Buchanan

Sociétés	Poste	Début
Allecra Therapeutics GmbH	Directeur/Membre du Conseil	01/01/2013
Aurealis Oy	Directeur/Membre du Conseil	-
Aurealis Pharma AG	Directeur/Membre du Conseil	-
Celloryx AG	Directeur/Membre du Conseil	-

Anciens postes connus de Iain Peter Murray Buchanan

Sociétés	Poste	Fin
SYNAIRGEN PLC	Directeur/Membre du Conseil	01/12/2022
NOXXON Pharma AG	Directeur Général	16/06/2015
Novexel SA	Directeur Général	01/01/2010
VERTEX PHARMACEUTICALS INCORPORATED	Corporate Officer/Principal	-
Cilag AG	Corporate Officer/Principal	-